title: Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Jahns
authors.forename: Dorothea
authors.initials: D
authors.lastname: Friess
authors.forename: Franziska
authors.initials: F
authors.lastname: Demarmels Biasiutti
authors.forename: Johanna A
authors.initials: JA
authors.lastname: Kremer Hovinga
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Alberio
authors.forename: Johannes
authors.initials: J
authors.lastname: Oldenburg
authors.forename: Bernhard
authors.initials: B
authors.lastname: Lämmle
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Colucci
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects; D000990:Antithrombin III / Q000235:genetics; D020152:Antithrombin III Deficiency / Q000150:complications / Q000188:drug therapy* / Q000235:genetics*; D005164:Factor IX / Q000235:genetics*; D006406:Hematoma / Q000097:blood / Q000209:etiology*; D006801:Humans; D008297:Male; D009135:Muscular Diseases / Q000097:blood / Q000209:etiology; D009154:Mutation; D010644:Phenprocoumon / Q000009:adverse effects; D011498:Protein Precursors / Q000235:genetics*; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D011498:Protein Precursors; C542513:SERPINC1 protein, human; C049838:factor IX Cambridge; D014812:Vitamin K; D000990:Antithrombin III; D005164:Factor IX; D010644:Phenprocoumon